First Horizon National (NYSE:FHN), Horizon Pharma (NASDAQ:HZNP), Salix Pharmaceuticals (NASDAQ:SLXP), Honeywell International (NYSE:HON) | The Cinema Post
Sunday , September 23 2018
Home / Business News / First Horizon National (NYSE:FHN), Horizon Pharma (NASDAQ:HZNP), Salix Pharmaceuticals (NASDAQ:SLXP), Honeywell International (NYSE:HON)

First Horizon National (NYSE:FHN), Horizon Pharma (NASDAQ:HZNP), Salix Pharmaceuticals (NASDAQ:SLXP), Honeywell International (NYSE:HON)

First Horizon National Corporation (NYSE:FHN) (Full FREE Analysis of FHN And Be Sure To Notice The Intermediate Period) released third quarter earnings of $0.19 per share.  The regional bank was chiefly strong in the third quarter, with pre-tax income up 9% from second quarter. The bankers at First Tennessee surged commercial loans, as well as they continued to earn business in the bank’s specialty lending segments and growth markets of Middle Tennessee, Houston and the Mid-Atlantic region that includes the Carolinas, Virginia and North Florida. Share price of First Horizon National Corporation (NYSE:FHN) climbed 0.61% to closed at $11.47 with the traded volume of 2.57 million shares as compared to the average volume of 2.67 million in last session.

Horizon Pharma PLC (NASDAQ:HZNP) (Where Profit in a bull market, collect dividends along the way! Read Full Report Here) released that the purchase of the U.S. rights to PENNSAID 2% w/w from Nuvo Research Inc. for a one-time payment of $45 million in cash. PENNSAID 2% is approved in the U.S. for the treatment of the pain of osteoarthritis of the knee(s).  Horizon Pharma PLC (NASDAQ:HZNP) saw as a gainer stock in last session, rose 5.32% to finished at $11.67 with the overall traded volume of 1.70 million shares.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) (Read Experts View Here on SLXP Upcoming Performance) released that presentations associated to research of two of the firm’s products are scheduled to take place during the American College of Gastroenterology 2014 Annual Scientific Meeting. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) stock increase of 1.91% to closed at $140.00 with the total traded volume of 2.75 million shares. The consensus average revenue estimates are $394.64M for latest quarter, at the same time as 18 experts predict $436.63M revenues for the next three months of 2014.

Honeywell International Inc.(NYSE:HON) (Get Visual Access about Inside Factors Trade Here) released its third quarter (Sep) earnings of $1.47 per share, including $0.04 from a lower tax rate, $0.06 improved than the Capital IQ Consensus of $1.41; revenues rose 4.8% year/year to $10.11B as compared to the $10.04B consensus. Honeywell International Inc.(NYSE:HON) has its total traded volume during previous session was 7.84 million shares with share price change of 4.25% to settled at $90.06.

For latest Market Updates Subscribes Here

 

Facebook Comments